A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579 · PHASE3 · RECRUITING · Sponsor: Eli Lilly and Company · Conditions: Overweight, Prediabetic State,
PR
By Priya Raman · Science Reporter
Nov 5 07:00 ETSource: ClinicalTrials.gov
From the source
Read at clinicaltrials.govA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579 · PHASE3 · RECRUITING · Sponsor: Eli Lilly and Company · Conditions: Overweight, Prediabetic State, Prehypertension.
Source URL https://clinicaltrials.gov/study/NCT07794579
